JDD March 2021 Issue Highlights: From OTC Products for Acne to MMS for Genital Skin Cancer
The March issue of the Journal of Drugs in Dermatology features an outstanding line-up of articles with topics ranging from OTC products for acne to Mohs Micrographic Surgery for genital skin cancer. Straight from the JDD Editor’s desk, we share this month’s issue highlights:
Advisors agreed that OTC products and skincare recommendations, in addition to the use of prescription medications, …
The March issue of the Journal of Drugs in Dermatology features an outstanding line-up of articles with topics ranging from OTC products for acne to Mohs Micrographic Surgery for genital skin cancer. Straight from the JDD Editor’s desk, we share this month’s issue highlights:
Advisors agreed that OTC products and skincare recommendations, in addition to the use of prescription medications, … 
Straight from the desk of ODAC Medical Director, Dr. Adam Friedman, we share what’s popping in acne (spoiler alert: quite a lot!). According to Dr. Friedman, the innovation drought is over! Watch as he reviews all new topical and oral therapeutics (some of which are completely new active agents) and while at it, shares and debunks important information related to the management of acne vulgaris … 
The December issue of the Journal of Drugs in Dermatology focuses on a variety of topics ranging from plaque psoriasis and infantile hemangioma to suturing wounds under tension and cannabinoid gel on sensitive dry skin. And an incredible line-up of articles to finish 2020 strong! Straight from the JDD Editor’s desk, we share this month’s issue highlights:
Oxytocin Levels Inversely Correla … 
You are at the end of a busy afternoon clinic, with only a single patient standing between you and freedom to go visit a good friend and watch the Stanley Cup playoffs, of course after completing a metric ton of electronic charting. The chart in the door (or more likely on the EMR tablet) says “CHIEF COMPLAINT: ACNE”. Do you smile or groan? Acne vulgaris, or “common” acne, is itself among … 
Acne vulgaris is one of the most common reasons for visiting the dermatologist. Topical retinoids are a mainstay of and considered first-line treatment, but patients often face issues with tolerability, which can impact adherence to therapy. We continue our series, Therapeutic Cheat Sheet, with a closer look at the recently FDA approved trifarotene.
[caption id="attachment_10430" align="alignle … 